Adjuvant Melatonin for Uveal Melanoma

Clinical trial NCT05502900 · RECRUITING

Trial details

NCT number: NCT05502900
Sponsor: Gustav Stalhammar
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Uveal Melanoma Uveal Melanoma, Posterior, Medium/Large Size Eye Cancer, Intraocular Melanoma

Start date: 2022-10-02
Primary completion: 2031-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.